Skip to main content

SBTi validates three firms’ climate targets

28th November 2022

Submitted by:

Andrew Warmington

The Science Based Target initiative (SBTi), a collaboration between the United Nations Global Compact, World Resources Institute, the Climate Disclosure Project and the World Wide Fund for Nature (WWF) to drive corporate climate action, has validated the latest greenhouse gas reduction (GHG) targets of three chemical companies as both science-based and aligned with the UN Paris Agreement to limit the global temperature rise to no more than 1.5ºC this century.

DSM set its first target in 2016 of reducing Scope 1 and 2 GH emissions by 2030 and achieved this in 2019. The company updated to 50% in 2021 and again to 59% in August 2033, following continuous assessment of plans to achieve net-zero by 2050 if not sooner. As part of this ambition, DSM is already aiming to source 100% of its electricity worldwide from renewable sources by 2030.

Danish enzyme specialist Novozymes now aims to reduce absolute CO2 emissions from operations and from its supply chain by 75% and 35% respectively by 2030 from a 2018 base year and to source all of its electricity from renewable sources by 2025, up from 37% in 2018. Where possible, added CEO Ester Baiget, it will seek to “give back parts of our excess industrial heat to our local communities”. In the longer term,

Novozymes is committing to reduce absolute Scope 1, 2 and 3 emissions by 90% from 2018 to 2050. This includes biogenic emissions and removals associated with the use of bioenergy. Direct emission reductions will be prioritised and all residual emissions will be neutralised, if applicable, in line with SBTi criteria before reaching net-zero.

The SBTi has also validated Umicore’s targets to reduce Scope 1 and Scope 2 GHG emissions by 50% from a 2019 baseline and its Scope 3 emissions by 42% of CO2/tonne of purchased materials. These near-term targets are embedded in its 2030 RISE growth strategy and part of its longer-term  commitment to reach net zero emissions in 2035.

UPL to split out specialities

Indian agrochemicals giant UPL has announced plans to transfer its speciality chemicals business, including agrochemical

Submitted by:

Andrew Warmington

AI for SAPs

Together with Algo Artis, Japan’s Nippon Shokubai has developed an algorithm-based means for the production

Submitted by:

Andrew Warmington

Nippon Shokubai's API Facility in Japan

Nucleic acid API boost

Nippon Shokubai is to expand its GMP capacity for nucleic APIs tenfold It will install

Submitted by:

Andrew Warmington

Flamma's facility in Dalian

Flamma opens in China

Italian CDMO Flamma Group has officially opened its new cGMP plant at Dalian, China, where

Submitted by:

Andrew Warmington

GL Chemtec has opened a new kilo lab

GL Chemtec completes kilo lab

CDMO GL Chemtec has announced the completion of a cGMP kilo lab at Oakville, Ontario

Submitted by:

Andrew Warmington

Sterling's facility at Deeside, UK

CDMOs in ADC investments

Five CDMOs across the world have separately announced investments in antibody-drug conjugates (ADCs). Piramal Pharma is

Submitted by:

Andrew Warmington

Halozyme has dropped its approach to buy Evotec

Halozyme abandons Evotec bid

San Diego-based biopharmaceutical company Halozyme Therapeutics has withdrawn the offer it made for Evotec after

Submitted by:

Andrew Warmington

Afyren Neoxy plant

Milestones for two greentech firms

Afyren has achieved continuous production at its Afyren Neoxy plant at Clermont-Ferrand (pictured)

Submitted by:

Andrew Warmington

Origin by Ocean derives its materials from sargassum

CABB in algae biorefinery deal

CABB has agreed a strategic partnership to establish a first-in-kind algae biorefinery at its site at Kokkola

Submitted by:

Andrew Warmington

First waste-based biosurfactants

Belgian start-up AmphiStar has launched what it claims are the first fully upcycled biobased surfactants

Submitted by:

Andrew Warmington

Aether to supply Seqens

Indian firm Aether Industries has entered into a manufacturing agreement with Chemoxy International, a UK-based

Submitted by:

Andrew Warmington

New model for biocatalysts

BASF, the Austrian Research Centre of Industrial Biotechnology (ACIB) and the University of Graz in

Submitted by:

Andrew Warmington

CBE JU funds 31 more projects

The Circular Bio-based Europe Joint Undertaking (CBE JU), a €2 billion partnership between the EU

Submitted by:

Andrew Warmington

Ribbon cutting ceremony at Lubrizol's new office

Lubrizol opens London office

Lubrizol has opened a new office in Hammersmith, London. This will be home to a

Submitted by:

Andrew Warmington

Sudarshan to buy Heubach

India’s Sudarshan Chemical Industries (SCIL) has entered into a definitive agreement to acquire the Heubach

Submitted by:

Andrew Warmington

Alliance in natural fragrances

Sensegen, a US-based specialist in biotech-enabled fragrances, notably a new class of natural musk raw

Submitted by:

Andrew Warmington

Croda breaks ground in China

Croda International has broken ground for a low-carbon, multi-purpose production facility on a greenfield site

Submitted by:

Andrew Warmington

CCT collaboration for Givaudan

Flavours and fragrances giant Givaudan has agreed a research collaboration for the development of sustainable

Submitted by:

Andrew Warmington

REACH Authorisation

Candidate List ‘reaches’ 250

The European Chemicals Agency (ECHA) has added three more substances to the Candidate List of

Submitted by:

Andrew Warmington

Staff at Brenntag's newly acquired Czech site

CO2-free distribution site first

Brenntag has officially inaugurated what it claims to be the first CO2-emission-free chemical distribution site

Submitted by:

Andrew Warmington